Login to Your Account



Biotech Diaries

Sciclone’s Blobel Offers Peek at Innovative Firm Operating in China

By Shannon Ellis
Staff Writer

Wednesday, November 27, 2013

BEIJING – Friedhelm Blobel, CEO and president of Sciclone, knows about running a specialty pharmaceutical company in China. His company, based in Foster City, Calif., and listed on Nasdaq, has a 17-year track record in China selling its $100 million-a-year drug Zadaxin.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription